Cipher Pharmaceuticals Statistics
Total Valuation
CPHRF has a market cap or net worth of 234.28 million. The enterprise value is 253.33 million.
| Market Cap | 234.28M |
| Enterprise Value | 253.33M |
Important Dates
The last earnings date was Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 25.61M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.75% |
| Shares Change (QoQ) | +2.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 14.86M |
Valuation Ratios
The trailing PE ratio is 25.34.
| PE Ratio | 25.34 |
| Forward PE | n/a |
| PS Ratio | 5.93 |
| PB Ratio | 2.23 |
| P/TBV Ratio | 21.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 10.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.41, with an EV/FCF ratio of -4.32.
| EV / Earnings | 27.40 |
| EV / Sales | 6.23 |
| EV / EBITDA | 19.41 |
| EV / EBIT | 34.49 |
| EV / FCF | -4.32 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.38.
| Current Ratio | 2.28 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 3.19 |
| Debt / FCF | -0.69 |
| Interest Coverage | 10.27 |
Financial Efficiency
Return on equity (ROE) is 9.69% and return on invested capital (ROIC) is 3.85%.
| Return on Equity (ROE) | 9.69% |
| Return on Assets (ROA) | 3.49% |
| Return on Invested Capital (ROIC) | 3.85% |
| Return on Capital Employed (ROCE) | 4.91% |
| Revenue Per Employee | 7.90M |
| Profits Per Employee | 1.85M |
| Employee Count | 5 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 2.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.12% in the last 52 weeks. The beta is 0.70, so CPHRF's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +36.12% |
| 50-Day Moving Average | 8.81 |
| 200-Day Moving Average | 10.10 |
| Relative Strength Index (RSI) | 48.75 |
| Average Volume (20 Days) | 10,915 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CPHRF had revenue of 39.52 million and earned 9.25 million in profits. Earnings per share was 0.36.
| Revenue | 39.52M |
| Gross Profit | 28.43M |
| Operating Income | 7.14M |
| Pretax Income | 1.87M |
| Net Income | 9.25M |
| EBITDA | 12.52M |
| EBIT | 7.14M |
| Earnings Per Share (EPS) | 0.36 |
Balance Sheet
The company has 22.00 million in cash and 40.51 million in debt, giving a net cash position of -18.51 million.
| Cash & Cash Equivalents | 22.00M |
| Total Debt | 40.51M |
| Net Cash | -18.51M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 105.24M |
| Book Value Per Share | 4.01 |
| Working Capital | 22.56M |
Cash Flow
In the last 12 months, operating cash flow was 21.33 million and capital expenditures -80.04 million, giving a free cash flow of -58.71 million.
| Operating Cash Flow | 21.33M |
| Capital Expenditures | -80.04M |
| Free Cash Flow | -58.71M |
| FCF Per Share | n/a |
Margins
Gross margin is 71.95%, with operating and profit margins of 18.07% and 23.40%.
| Gross Margin | 71.95% |
| Operating Margin | 18.07% |
| Pretax Margin | 4.74% |
| Profit Margin | 23.40% |
| EBITDA Margin | 31.67% |
| EBIT Margin | 18.07% |
| FCF Margin | n/a |
Dividends & Yields
CPHRF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.75% |
| Shareholder Yield | -1.75% |
| Earnings Yield | 3.95% |
| FCF Yield | -25.06% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |